Cloprostenol,
Cloprostenol Monosodium Salt,
Cloprostenol Sodium,
Estrumate,
ICI 80,966,
ICI-80,966,
ICI80,966,
Monosodium Salt, Cloprostenol,
Oestrophan,
Salt, Cloprostenol Monosodium,
Sodium, Cloprostenol,
Cloprostenol sodium,
55028-72-3,
(+)-Cloprostenol sodium,
Estrumate,
(+/-)-Cloprostenol sodium salt,
(+)-Cloprostenol,
UNII-81129I41BJ,
MFCD05863539,
81129I41BJ,
Cloprostenol sodium salt,
62561-03-9,
ICI 80996,
Estroplan,
54276-21-0,
NCGC00165774-02,
C22H28ClNaO6,
(+)-CLOPROSTENOL SODIUM SALT,
Cloprostenol sodium [USAN:USP],
Sodium (Z)-7-((1R,2R,3R,5S)-2-((R,E)-4-(3-chlorophenoxy)-3-hydroxybut-1-en-1-yl)-3,5-dihydroxycyclopentyl)hept-5-enoate,
EINECS 259-439-3,
CLOPROSTENOL Na,
D-Cloprostenol sodium salt,
Cloprostenol sodium, (+)-,
DSSTox_CID_26500,
DSSTox_RID_81669,
DSSTox_GSID_46500,
SCHEMBL28242,
MLS000028831,
(5Z)-rel-Cloprostenol Sodium,
BML2-G09,
CHEMBL1520583,
DTXSID1046500,
HMS1361O21,
HMS2235O09,
HMS3268J10,
EX-A1351,
Tox21_112261,
AKOS015967190,
AKOS024457034,
AC-6102,
ICI 80,996,
RP17749,
NCGC00159550-01,
(+-)-Sodium (Z)-7-((1R*,2R*,3R*,5S*)-2-((E)-(3R*)-4-(m-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-5-heptenoate,
AC-25916,
AN-10391,
M202,
SMR000058871,
CAS-55028-72-3,
X2625,
(+/-)-16-(3-Chlorophenoxy)-9,11,15R-trihydroxy-17,18,19,20-tetranorprosta-5Z,13E-dien-1-oic acid sodium salt hydrate,
J-524247,
J-524252,
UNII-886SAV9675 component IFEJLMHZNQJGQU-KXXGZHCCSA-M,
(5Z)-rel-7-[(1R,2R,3R,5S)-2-[(1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-butenyl]-3,5-dihydroxycyclopentyl]-5-heptenoic acid monosodium salt,
(Z)-7-[2beta-[(1E,3R)-4-(3-Chlorophenoxy)-3-hydroxy-1-butenyl]-3alpha,5alpha-dihydroxycyclopentan-1alpha-yl]-5-heptenoic acid sodium salt,
5-Heptenoic acid, 7-((1R,2R,3R,5S)-2-((1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-buten-1-yl)-3,5-dihydroxycyclopentyl)-, sodium salt (1:1), (5Z)-,
5-Heptenoic acid, 7-((1R,2R,3R,5S)-2-((1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-, monosodium salt, (5Z)-rel-,
5-Heptenoic acid, 7-(2-(4-(3-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-, (1alpha(Z),2beta(1E,3R*),3alpha,5alpha)-, sodium salt, (+-)-,
5-Heptenoic acid, 7-(2-(4-(3-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-, monosodium salt, (1alpha(Z),2beta(1E,3R*),3alpha,5alpha)-(+-)-,
Sodium (1alpha(Z),2beta(1E,3R*),3alpha,5alpha)-(1)-7-(2-(4-(3-chlorophenoxy)-3-hydroxybut-1-enyl)-3,5-dihydroxycyclopentyl)hept-5-enoate,
Sodium (E)-7-((1R,2R,3R,5S)-2-((R,E)-3-(3-Chlorophenoxy)-3-hydroxyprop-1-en-1-yl)-3,5-dihydroxycyclopentyl)hept-5-enoate,
sodium (Z)-7-[(1R,2R,3R,5S)-2-[(E,3R)-4-(3-chlorophenoxy)-3-hydroxy-but-1-enyl]-3,5-dihydroxy-cyclopentyl]hept-5-enoate,
Dalmazin,
-Cloprostenol,
D-Cloprostenol,
R-Cloprostenol,
Dalmaprost D,
Cloprostenol, (+)-,
UNII-52EJR3Y9IN,
C22H29ClO6.Na,
Cloprostenol sodium [USAN],
UNII-886SAV9675,
C22-H28-Cl-Na-O6,
(+)-Cloprostenol (sodium salt),
886SAV9675,
CID6852387,
2027S,
16-(m-Chlorophenoxy)-17,18,19,20-tetranorprostaglandin F2alpha,
5-Heptenoic acid, 7-((1R,2R,3R,5S)-2-((1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-buten-1-yl)-3,5-dihydroxycyclopentyl)-, (5Z)-,
5-Heptenoic acid, 7-((1R,2R,3R,5S)-2-((1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-, (5Z)-,
5-Heptenoic acid, 7-[(1R,2R,3R,5S)-2-[(1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-butenyl]-3,5-dihydroxycyclopentyl]-, monosodium salt, (5Z)-rel-,
5-Heptenoic acid, 7-[2-[4-(3-chlorophenoxy)-3-hydroxy-1-butenyl]-3,5-dihydroxycyclopentyl]-, monosodium salt, [1.alpha.(Z),2.beta.(1E,3R*),3.alpha.,5.alpha.]-(.+-.)-,
5-Heptenoic acid, 7-[2-[4-(3-chlorophenoxy)-3-hydroxy-1-butenyl]-3,5-dihydroxycyclopentyl]-, monosodium salt, [1.alpha.(Z),2.beta.(1E,3R*),3.alpha.,5.alpha.]-(.+.)-,
Sodium [1alpha(Z),2beta(1E,3R*),3alpha,5alpha]-(+-)-7-[2-[4-(3-chlorophenoxy)-3-hydroxybut-1-enyl]-3,5-dihydroxycyclopentyl]hept-5-enoate,